Skip to main content
. 2020 Mar 16;52(2):335–350. doi: 10.4143/crt.2020.206

Table 7.

Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2017 in Korea

Site/Type Both sexes
Men
Women
1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea)
All sites 42.9 45.1 54.1 65.5 70.7 70.4 27.5 33.2 36.3 45.6 56.8 63.1 63.5 30.3 55.1 56.4 64.3 74.4 78.4 77.5 22.4
All sites excluding thyroid 41.2 43.3 50.8 59.0 64.2 65.0 23.8 32.7 35.8 44.7 54.6 60.3 61.0 28.3 52.6 53.5 59.1 65.0 69.3 70.1 17.5
Lip, oral cavity, and pharynx 42.1 47.4 54.5 61.0 65.3 66.7 24.6 36.6 41.7 49.6 56.9 61.7 63.7 27.1 59.3 64.5 68.1 72.0 74.4 74.1 14.8
Esophagus 14.0 15.7 21.5 29.9 36.4 38.0 24.0 13.1 14.8 20.7 29.3 36.1 37.5 24.4 25.0 25.9 29.8 37.1 39.7 42.2 17.2
Stomach 43.9 47.3 58.0 68.4 75.9 76.5 32.6 43.9 47.6 58.7 69.1 76.8 77.5 33.6 43.7 46.8 56.6 67.0 74.0 74.6 30.9
Colon and rectum 56.2 58.8 66.9 73.9 76.2 75.0 18.8 56.6 59.8 68.8 75.8 77.9 76.6 20.0 55.7 57.7 64.4 71.1 73.7 72.6 16.9
Liverb) 11.7 14.1 20.5 28.2 34.3 35.6 23.9 10.8 13.8 20.4 28.2 34.8 36.4 25.6 15.0 15.1 20.9 28.3 32.7 33.2 18.2
Gallbladderc) 18.7 20.7 23.1 26.9 28.8 28.9 10.2 18.0 21.1 23.5 27.8 29.5 29.7 11.7 19.3 20.3 22.7 26.0 28.1 28.0 8.7
Pancreas 10.6 8.7 8.4 8.5 10.8 12.2 1.6 10.0 8.3 8.4 8.3 10.2 11.8 1.8 11.5 9.2 8.4 8.8 11.4 12.5 1.0
Larynx 61.6 63.3 66.5 73.2 75.0 77.0 15.4 62.1 63.7 67.1 73.5 75.4 77.4 15.3 56.3 58.9 58.6 68.0 69.2 69.6 13.3
Lungd) 12.5 13.6 16.5 20.2 27.5 30.2 17.7 11.6 12.4 15.3 18.0 23.2 25.2 13.6 15.8 17.5 20.1 26.0 37.2 41.5 25.7
Breast 79.2 83.6 88.6 91.2 92.7 93.2 14.0 77.1 84.3 87.5 89.9 89.4 94.7 17.6 79.2 83.6 88.7 91.2 92.7 93.2 14.0
Cervix uteri 78.3 80.3 81.5 80.7 80.2 80.2 1.9 - - - - - - - 78.3 80.3 81.5 80.7 80.2 80.2 1.9
Corpus uteri 82.9 82.0 84.8 86.5 87.8 88.2 5.3 - - - - - - - 82.9 82.0 84.8 86.5 87.8 88.2 5.3
Ovary 60.1 59.4 61.7 61.2 64.3 64.9 4.8 - - - - - - - 60.1 59.4 61.7 61.2 64.3 64.9 4.8
Prostate 59.1 69.2 81.0 91.9 94.1 94.1 35.0 59.1 69.2 81.0 91.9 94.1 94.1 35.0 - - - - - - -
Testis 87.4 90.4 90.7 93.1 95.1 95.2 7.8 87.4 90.4 90.7 93.1 95.1 95.2 7.8 - - - - - - -
Kidney 64.3 67.0 73.6 78.6 82.4 83.1 18.8 63.5 65.3 73.0 78.4 82.1 83.1 19.6 65.9 70.3 74.9 78.9 83.2 82.9 17.0
Bladder 70.7 73.6 76.0 77.2 76.4 76.8 6.1 71.6 75.1 77.8 79.2 78.3 78.8 7.2 67.1 67.3 69.1 69.1 68.6 68.9 1.8
Brain and CNS 40.4 39.9 41.0 42.9 41.3 40.8 0.4 39.1 38.7 40.3 41.3 39.7 39.2 0.1 42.1 41.4 41.8 44.6 43.0 42.5 0.4
Thyroid 94.5 95.0 98.4 100.0 100.2 100.1 5.6 87.9 89.6 96.0 100.2 100.6 100.4 12.5 95.7 96.0 98.7 99.9 100.1 100.0 4.3
Hodgkin lymphoma 70.1 71.9 76.7 81.0 82.2 83.7 13.6 69.2 69.3 74.7 80.8 81.7 81.3 12.1 71.5 77.3 80.7 81.5 83.1 87.8 16.3
Non-Hodgkin lymphoma 48.3 51.1 56.0 59.4 62.8 63.2 14.9 46.9 49.6 55.0 59.2 62.7 63.9 17.0 50.6 53.3 57.5 59.7 62.9 62.2 11.6
Multiple myeloma 23.5 21.0 29.7 35.0 41.2 43.3 19.8 23.0 19.1 29.8 35.2 40.8 43.6 20.6 24.1 23.3 29.5 34.7 41.7 43.1 19.0
Leukemia 27.5 34.3 42.0 47.7 51.9 53.0 25.5 27.3 33.3 41.8 46.9 52.2 53.6 26.3 27.8 35.5 42.2 48.7 51.5 52.3 24.5
Other and ill-defined 44.5 48.3 57.8 67.6 72.6 74.0 29.5 39.6 44.7 54.0 63.8 69.3 70.9 31.3 50.1 52.6 61.9 71.5 76.0 77.0 26.9

CNS, central nervous system.

a)

Absolute percentage change in 5-year relative survival from 1993 to 1995 and 2013 to 2017,

b)

Includes the liver and intrahepatic bile duct,

c)

Includes the gallbladder and other/unspecified parts of the biliary tract,

d)

Includes the lung and bronchus.